| Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES COVID- 19 The COVID- 19 19 not 2021 2020. 19 The Company USANA Health Sciences, Inc. develops and manufactures high quality, science-based nutritional and personal care products that are sold internationally through a direct selling channel. The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two 1 2 three ( 1 Asia Pacific – (i) Greater China – Hong Kong, Taiwan, and China. The Company’s business in China is conducted by BabyCare Holdings, Ltd. (“BabyCare”), the Company’s wholly-owned subsidiary. (ii) Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand and Indonesia. (iii) North Asia – Japan and South Korea. ( 2 Americas and Europe – United States, Canada, Mexico, Colombia, the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands. Principles of Consolidation and Basis of Presentation The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“US GAAP”). Use of Estimates The preparation of Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may Fiscal Year The Company operates on a 52/53 December 31. 2021 2019 52 2020 53 2021 January 3, 2021 January 1, 2022 ( 2021 2020 December 29, 2019 January 2, 2021 ( 2020 2019 December 30, 2018 December 28, 2019 ( 2019 Fair Value Measurements The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are: ● Level 1 ● Level 2 1 ● Level 3 As of January 1, 2022 January 2, 2021 Fair Value Measurements Using January 1, Inputs 2022 Level 1 Level 2 Level 3 Money market funds included in cash equivalents $ 163,619 $ 163,619 $ — $ — Foreign currency contracts included in other current liabilities (461 ) — (461 ) — $ 163,158 $ 163,619 $ (461 ) $ — Fair Value Measurements Using January 2, Inputs 2021 Level 1 Level 2 Level 3 Money market funds included in cash equivalents $ 224,092 $ 224,092 $ — $ — Foreign currency contracts included in other current liabilities (1,470 ) — (1,470 ) — $ 222,622 $ 224,092 $ (1,470 ) $ — There were no The majority of the Company’s non-financial assets, which include long-lived assets, are not January 1, 2022 January 2, 2021 Fair Value of Financial Instruments As of January 1, 2022 January 2, 2021 Translation of Foreign Currencies The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three January 1, 2022 January 2, 2021 Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three January 1, 2022 January 2, 2021 Restricted Cash The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $3,146 as of January 1, 2022 January 2, 2021 Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first first Accounts Receivable Accounts receivable are recorded at the invoiced amount and do not Income Taxes The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities. The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not not” not fifty Property and Equipment Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not Leases With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. 2026. At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments. Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 not may Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 not The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income. Goodwill Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not not may not not 2021 2020 2019 no Intangible Assets Intangible assets represent amortized and indefinite-lived intangible assets acquired in connection with the purchase of the Company’s China subsidiary in 2010. may not Indefinite-lived intangible assets are not may not not 2021 2020 2019 Investment in Equity Securities Equity securities (“securities”) without readily determinable fair value that are not 2020, may The initial value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are measured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2021 2020, At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may not 2021 2020, Nonqualified Deferred Compensation In 2021, 50% 80% no January 1, 2022 Self - Insurance The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,390. A liability is accrued for all unpaid claims. Total expense under this self-insurance program was $12,349, $11,798, and $11,846 in 2021 2020 2019 Derivative Financial Instruments The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s risk management policies, the Company does not The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated. During 2021 2020 2019 f $98,684, 2021 2020 2019, January 1, 2022 January 2, 2021 Subsequent to January 1, 2022 , on January 13, 2022 Common Stock Share Repurchases The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of January 1, 2022 no no Revenue Recognition Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five 1 identification of the contract with a customer; 2 identification of the performance obligations in the contract; 3 determination of the transaction price; 4 allocation of the transaction price to the performance obligations in the contract; and 5 recognition of revenue when or as a performance obligation is satisfied. Product Revenue A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third not The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not Initial product orders with a new customer may two Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may Shipping and handling activities are performed upon delivery to the third With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders is remote. Other Revenue Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts. The following table presents Other Revenue for the periods indicated: Year Ended 2021 2020 2019 Other Revenue $ 3,825 $ 3,805 $ 3,059 Revenue Disaggregation Disaggregation of revenue by geographical region and major product line is included in Note L – Segment Information. Contract Balances When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance). Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. The Company typically does not $0 January 1, 2022 January 2, 2021 The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period. January 1, January 2, 2022 2021 Contract liabilities at beginning of period $ 15,952 $ 13,852 Increase due to deferral of revenue at period end 19,635 15,952 Decrease due to beginning contract liabilities recognized as revenue (15,952 ) (13,852 ) Contract liabilities at end of period $ 19,635 $ 15,952 Product Return Policy All product orders that are unused and returned within the first one may 2021 2020 2019 Associate Incentives Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales. Selling, General and Administrative Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses. Equity-Based Compensation The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. Equity-based compensation expense is recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Further information regarding equity awards can be found in Note K – Equity-Based Compensation. Advertising Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Advertising expense totaled $12,399, $9,853, and $11,615 in 2021 2020 2019 Research and Development Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Research and development expense totaled $11,112, $10,633, and $10,259 in 2021 2020 2019 Earnings Per Share Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not not Recent Accounting Pronouncements Adopted accounting pronouncements In December 2019, No. 2019 12, 740 2019 12 740 December 15, 2020 2019 12 first April 3, 2021 not In January 2021, No. 2021 01 848 848 848, 848 not December 31, 2022, December 31, 2022, December 31, 2022, December 31, 2022, December 31, 2022). may March 12, 2020, January 7, 2021, 2021 01 not No |
